Literature DB >> 7753417

Effect of GSH on cerebral vasospasm in dogs.

S Haciyakupoğlu1, F Ildan, S Polat, E Cetinalp, B Boyar, M Kaya.   

Abstract

Reduced glutathinone (tau-glutamylcysteinglycine, GSH) is a scavenger for oxygen radicals and plays in important role in protection of cells from ischemia and from the harmful effects of free oxygen radicals. Free oxygen radicals due to cerebral vasospasm increase in both vasospasm and proliferative vasculopathy. This experiment was performed to determine whether GSH plays a role in cerebral vasospasm after subarachnoid hemorrhage by preventing the harmful effects of free oxygen radicals. In this study, GSH was administered intraarterially and intracisternally following vasospasm of the canine basilar artery. Less vasospasm was observed in the group treated with GSH intraarterially following subarachnoid hemorrhage than in the one treated with GSH intracisternally and in the control group. The arterial wall was investigated ultrastructurally. We evaluated the effect of the anti-oxidating substance through the activity of superoxide dismutase in the arterial wall. We compared the effect of glutathione reductase in the two groups treated with GSH intraarterially and intracisternally. Arterial degeneration was more prominent in the group in which GSH was used intracisternally, while the superoxide dismutase levels were low. In contrast, arterial degeneration was less in the other group in which GSH was used intraarterially, while the superoxide dismutase levels were high.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7753417     DOI: 10.1007/BF00306819

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  21 in total

Review 1.  Pathophysiology of hemolysis in glucose-6-phosphate dehydrogenase deficiency.

Authors:  P Arese; A De Flora
Journal:  Semin Hematol       Date:  1990-01       Impact factor: 3.851

2.  Prevention of experimental subarachnoid hemorrhage-induced intracranial arterial vasonecrosis with phosphodiesterase inhibitor phthalazinol (EG-626).

Authors:  J F Alksne; P J Branson
Journal:  Stroke       Date:  1979 Nov-Dec       Impact factor: 7.914

3.  Attenuation of decompressive hypoperfusion and cerebral edema by superoxide dismutase.

Authors:  A Schettini; R H Lippman; E K Walsh
Journal:  J Neurosurg       Date:  1989-10       Impact factor: 5.115

4.  Glutathione and ascorbate during ischemia and postischemic reperfusion in rat brain.

Authors:  A J Cooper; W A Pulsinelli; T E Duffy
Journal:  J Neurochem       Date:  1980-11       Impact factor: 5.372

5.  Alterations in endothelium-dependent responsiveness of the canine basilar artery subarachnoid hemorrhage.

Authors:  P Kim; T M Sundt; P M Vanhoutte
Journal:  J Neurosurg       Date:  1988-08       Impact factor: 5.115

6.  Reversal of experimental delayed cerebral vasospasm by angiotensin-converting enzyme inhibition.

Authors:  H Gavras; P Andrews; N Papadakis
Journal:  J Neurosurg       Date:  1981-12       Impact factor: 5.115

7.  Effect of intracisternal antithrombin III on subarachnoid hemorrhage-induced arterial narrowing.

Authors:  D G Vollmer; K Hongo; N F Kassell; H Ogawa; T Tsukahara; R M Lehman
Journal:  J Neurosurg       Date:  1989-04       Impact factor: 5.115

8.  Delayed cerebral vasospasm is not reversible by aminophylline, nifedipine, or papaverine in a "two-hemorrhage" canine model.

Authors:  V G Varsos; T M Liszczak; D H Han; J P Kistler; J Vielma; P M Black; R C Heros; N T Zervas
Journal:  J Neurosurg       Date:  1983-01       Impact factor: 5.115

9.  Lipid peroxidation in focal cerebral ischemia.

Authors:  Y Kinuta; H Kikuchi; M Ishikawa; M Kimura; Y Itokawa
Journal:  J Neurosurg       Date:  1989-09       Impact factor: 5.115

Review 10.  Eicosanoids in the central nervous system.

Authors:  J B Leslie; W D Watkins
Journal:  J Neurosurg       Date:  1985-11       Impact factor: 5.115

View more
  1 in total

1.  Glutathione peroxidase and subarachnoid hemorrhage: implications for the role of oxidative stress in cerebral vasospasm.

Authors:  Gail J Pyne-Geithman; Danielle N Caudell; Porus Prakash; Joseph F Clark
Journal:  Neurol Res       Date:  2009-03       Impact factor: 2.448

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.